Denca is under control at SAFC plant in Scotland

Published: 6-Jun-2011
Manufacturing Pharmaceutical

Will supply full control system for IPB2 facility at Irvine

Denca is under control at SAFC plant in Scotland
Automation control systems specialist Denca Controls has been awarded the E&I controls contract for the new IPB2 facility being designed by laboratory and cleanroom specialist T Squared for SAFC, a leader in biochemical and organic chemical products, based in Irvine, Scotland.

The project involves building and automating a cell culture media, reagents and buffer solutions manufacturing system, CIP system, WFI/SIP system and filling system at the SAFC facility.

Denca, based in Widnes, Cheshire, will supply a full control system consisting of E&I design, manufacture of system control panels, including motor control panel, PLC/instrument control panel and multiple remote I/O, solenoid, HMI panels, system software and associated validation documentation to GAMP (Good Automated Manufacturing Practices), installation and testing/commissioning through to client handover.

See more

You may also like

Manufacturing
Denca designs control system for pharma facility

Denca designs control system for pharma facility

Read more
Project in Liverpool worth £500,000

Trending Articles

  1. IMA MED-TECH launches ASSEMBLA modular assembly platform for medical devices across full lifecycle The engineer-to-order system scales from 20 to 500+ parts per minute on a single extendable frame, supporting injectables, inhalers, diagnostics and wearables from clinical trials through high-volume industrial production
  2. Why integrated outsourcing wins in modern drug development Aligning drug substance and drug product development within a single outsourcing model accelerates timelines, sharpens CMC decisions and reduces risk by enabling parallel workstreams and shared governance
  3. Axplora consolidates UDCA manufacturing at FDA-approved Vizag site using green chemistry process The transition from Gropello Cairoli to India frees Farmabios to focus on HPAPI and steroid leadership, while Vizag's enzymatic synthesis route and backwards-integrated bile sourcing strengthen global API supply resilience
  4. Lonza appoints Hans Trees as Global Head of Communications Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

You may also like

Manufacturing
Denca designs control system for pharma facility

Denca designs control system for pharma facility

Project in Liverpool worth £500,000
Manufacturing
Non-invasive real-time liquid flowmeters

Non-invasive real-time liquid flowmeters

Biotech Fluidics offers a range of non-invasive flowmeters for real-time, non-invasive monitoring of liquid flow
Pharmaceutical
Grifols launches FESILTY fibrinogen concentrate in US for congenital fibrinogen deficiency

Grifols launches FESILTY fibrinogen concentrate in US for congenital fibrinogen deficiency

The FDA-approved plasma-derived concentrate enables rapid, predictable fibrinogen restoration in paediatric and adult patients — reconstituting in three minutes and offering a purified alternative to cryoprecipitate and fresh frozen plasma
Digital
ZoBio launches integrated DEL hit discovery service for challenging drug targets

ZoBio launches integrated DEL hit discovery service for challenging drug targets

The new library-agnostic platform combines DEL screening with X-ray crystallography, quantitative biophysics and off-DNA validation, delivering structurally characterised, progressible starting points beyond conventional hit identification
Manufacturing
Free E-book – Advanced Solutions for Polymer Processing and Analysis

Free E-book – Advanced Solutions for Polymer Processing and Analysis

New guide provides practical insights into extrusion optimisation, quality control, material characterisation, and sustainable polymer manufacturing
Sustainability
SCHOTT Pharma expands ready-to-use portfolio with sterile 1.5 ml cartridge

SCHOTT Pharma expands ready-to-use portfolio with sterile 1.5 ml cartridge

The 1.5 ml cartridge is the smallest format in SCHOTT Pharma’s sterile cartriQ portfolio, streamlining the pharmaceutical filling process for a wide range of drugs. It is optimised for the innovative diamond-shaped cartriQ nest design, enhancing efficiency and sustainability in fill-and-finish operations. The sterile 1.5 ml cartridge, in combination with pen or autoinjector systems, supports treatments for patients at home
Regulatory
How to avoid the top 5 pharma data integrity failures

How to avoid the top 5 pharma data integrity failures

Regulatory bodies like the MHRA and FDA expect every piece of environmental data to be accurate, complete, and traceable, from the moment it’s captured to the time it’s archived. We know there is no room for error in such a regulated industry
Subscribe now